|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates
|
|
|
|
For about as long as I've been writing The Niche, people have been asking about stem cells for MS. There's a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved in the US), other cell therapy approaches are being tested …
|
|
|
|
|
|
|
|
Some CAR-T may very rarely cause new cancers
|
|
|
|
The FDA issued a statement this week that there have been reports of new cases of blood cancer after patients received CAR-T therapies. The FDA specifically mentions T cell malignancies. New cancers in rare cases? In the announcement, FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies, the agency reported that …
|
|
|
|
|
|
|
|
Review of Docere Clinics run by Harry Adelson including total-body injections
|
|
|
|
In today's post, I reviewed a stem cell clinic firm called Docere Clinics. In my opinion, there are some concerning issues here and reasons for caution. One type of procedure at Docere is particularly surprising and raises risks in my view. What is Docere Clinics? | What kind of stem cells does Docere use? | What they claim to treat | Docere …
|
|
|
|
|
|
